Sakima A Smith1, Ayesha K Hasan2, Philip F Binkley3, Randi E Foraker4. 1. Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio; Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio; Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio; Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio; Division of Cardiology, The Ohio State University Medical Center, Columbus, Ohio. Electronic address: sakima.smith@osumc.edu. 2. Cardiac Transplant Program, The Ohio State University Medical Center, Columbus, Ohio; Cardiac Transplant Program, The Ohio State University Medical Center, Columbus, Ohio; Cardiac Transplant Program, The Ohio State University Medical Center, Columbus, Ohio. 3. Department of Internal Medicine, The Ohio State University, Columbus, Ohio; Department of Internal Medicine, The Ohio State University, Columbus, Ohio; Department of Internal Medicine, The Ohio State University, Columbus, Ohio; The Ohio State University College of Medicine, Columbus, Ohio; The Ohio State University College of Public Health, Columbus, Ohio. 4. The Ohio State University College of Public Health, Columbus, Ohio; Division of Epidemiology, The Ohio State University College of Public Health, Columbus, Ohio.
Abstract
BACKGROUND: There has been a steady increase of patients living in the community with Left Ventricular Assist Devices (LVADs). There is a significant gap in our fund of knowledge with respect to the impact that insurance and socioeconomic status has on outcomes for LVAD patients. We thus hypothesize that low neighborhood socioeconomic status and receipt of Medicaid, respectively, lead to earlier readmissions, earlier death, as well as longer time to transplantation among LVAD patients. METHODS: This was a retrospective review of 101 patients using existing data in the medical information warehouse database at The Ohio State University Medical Center. Primary outcomes measured included time to first event (first readmission or death), death, and time to rehospitalization. Our secondary outcome of interest included time from LVAD implantation to cardiac transplantation. RESULTS: Recipients of Medicaid did not have an increased risk of adverse events compared with patients without Medicaid coverage. Low Median Household Income (MHI) was associated with an increased risk of readmission (log-rank P = 0.0069) and time to first event (log-rank P = 0.0088). Bridge to transplantation was the only independent predictor of time to death (Hazard Ratio 2.1, [95% confidence interval = 1.03-4.37]). Low MHI and a history of atherosclerosis were both significant predictors for readmission and time to first event. Aldosterone antagonist use decreased the risk of readmission or time to first event by 46%. CONCLUSIONS: LVAD recipients with a low MHI were more likely to be readmitted to the hospital after LVAD implantation. Whether these patients are adequately monitored on an outpatient basis remains unclear.
BACKGROUND: There has been a steady increase of patients living in the community with Left Ventricular Assist Devices (LVADs). There is a significant gap in our fund of knowledge with respect to the impact that insurance and socioeconomic status has on outcomes for LVADpatients. We thus hypothesize that low neighborhood socioeconomic status and receipt of Medicaid, respectively, lead to earlier readmissions, earlier death, as well as longer time to transplantation among LVADpatients. METHODS: This was a retrospective review of 101 patients using existing data in the medical information warehouse database at The Ohio State University Medical Center. Primary outcomes measured included time to first event (first readmission or death), death, and time to rehospitalization. Our secondary outcome of interest included time from LVAD implantation to cardiac transplantation. RESULTS: Recipients of Medicaid did not have an increased risk of adverse events compared with patients without Medicaid coverage. Low Median Household Income (MHI) was associated with an increased risk of readmission (log-rank P = 0.0069) and time to first event (log-rank P = 0.0088). Bridge to transplantation was the only independent predictor of time to death (Hazard Ratio 2.1, [95% confidence interval = 1.03-4.37]). Low MHI and a history of atherosclerosis were both significant predictors for readmission and time to first event. Aldosterone antagonist use decreased the risk of readmission or time to first event by 46%. CONCLUSIONS:LVAD recipients with a low MHI were more likely to be readmitted to the hospital after LVAD implantation. Whether these patients are adequately monitored on an outpatient basis remains unclear.
Authors: Joseph G Rogers; Robin R Bostic; Kuo B Tong; Rob Adamson; Mark Russo; Mark S Slaughter Journal: Circ Heart Fail Date: 2011-11-03 Impact factor: 8.790
Authors: James K Kirklin; David C Naftel; Robert L Kormos; Lynne W Stevenson; Francis D Pagani; Marissa A Miller; J Timothy Baldwin; James B Young Journal: J Heart Lung Transplant Date: 2012-02 Impact factor: 10.247
Authors: Josef Stehlik; Leah B Edwards; Anna Y Kucheryavaya; Christian Benden; Jason D Christie; Anne I Dipchand; Fabienne Dobbels; Richard Kirk; Axel O Rahmel; Marshall I Hertz Journal: J Heart Lung Transplant Date: 2012-10 Impact factor: 10.247
Authors: Liviu Klein; Christopher M O'Connor; Jeffrey D Leimberger; Wendy Gattis-Stough; Ileana L Piña; G Michael Felker; Kirkwood F Adams; Robert M Califf; Mihai Gheorghiade Journal: Circulation Date: 2005-05-02 Impact factor: 29.690
Authors: Prateeti Khazanie; Bradley G Hammill; Chetan B Patel; Zubin J Eapen; Eric D Peterson; Joseph G Rogers; Carmelo A Milano; Lesley H Curtis; Adrian F Hernandez Journal: J Am Coll Cardiol Date: 2014-01-30 Impact factor: 24.094
Authors: James K Kirklin; David C Naftel; Robert L Kormos; Lynne W Stevenson; Francis D Pagani; Marissa A Miller; J T Baldwin; J Timothy Baldwin; James B Young Journal: J Heart Lung Transplant Date: 2013-02 Impact factor: 10.247
Authors: Tal Hasin; Yariv Marmor; Walter Kremers; Yan Topilsky; Cathy J Severson; John A Schirger; Barry A Boilson; Alfredo L Clavell; Richard J Rodeheffer; Robert P Frantz; Brooks S Edwards; Naveen L Pereira; John M Stulak; Lyle Joyce; Richard Daly; Soon J Park; Sudhir S Kushwaha Journal: J Am Coll Cardiol Date: 2012-12-05 Impact factor: 24.094
Authors: Asia McDavid; Kelly MacBrair; Sitaramesh Emani; Lianbo Yu; Peter H U Lee; Bryan A Whitson; Brent C Lampert; Riddhima Agarwal; Ahmet Kilic Journal: Interact Cardiovasc Thorac Surg Date: 2018-01-01
Authors: Kevin J Clerkin; Arthur Reshad Garan; Brian Wayda; Raymond C Givens; Melana Yuzefpolskaya; Shunichi Nakagawa; Koji Takeda; Hiroo Takayama; Yoshifumi Naka; Donna M Mancini; Paolo C Colombo; Veli K Topkara Journal: Circ Heart Fail Date: 2016-10 Impact factor: 8.790
Authors: Sarah Streeter Hutcheson; Victoria Phillips; Rachel Patzer; Andrew Smith; J David Vega; Alanna A Morris Journal: Clin Transplant Date: 2018-07-11 Impact factor: 2.863
Authors: Mustafa M Ahmed; Stephen M Magar; Eric I Jeng; George J Arnaoutakis; Thomas M Beaver; Juan Vilaro; Charles T Klodell; Juan M Aranda Journal: Clin Cardiol Date: 2018-11-20 Impact factor: 2.882
Authors: Sameed Ahmed M Khatana; Thomas C Hanff; Ashwin S Nathan; Elias J Dayoub; E Wilson Grandin; J Eduardo Rame; Alexander C Fanaroff; Jay Giri; Peter W Groeneveld Journal: Circ Heart Fail Date: 2021-05-15 Impact factor: 8.790
Authors: Inna Tchoukina; Keyur B Shah; Jennifer T Thibodeau; Jerry D Estep; Anuradha Lala; David E Lanfear; Nisha A Gilotra; Salpy V Pamboukian; Douglas A Horstmanshof; Dennis M Mcnamara; Donald C Haas; Ulrich P Jorde; Rhondalyn C Mclean; Thomas M Cascino; Shokoufeh Khalatbari; Blair Richards; Matheos Yosef; Cathie Spino; J Timothy Baldwin; Douglas L Mann; Keith D Aaronson; Garrick C Stewart Journal: J Card Fail Date: 2019-12-04 Impact factor: 6.592